Pura Vida Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-62,300
Closed -$4.78M 263
2021
Q4
$4.78M Buy
+62,300
New +$4.96M 0.17% 118
2021
Q2
Sell
-104,800
Closed -$7.71M 260
2021
Q1
$7.71M Buy
+104,800
New +$7.73M 0.22% 94
2018
Q2
Sell
-209,600
Closed -$10.9M 110
2018
Q1
$10.9M Buy
+209,600
New +$11.3M 6.44% 2
2017
Q3
Sell
-104,800
Closed -$6.41M 87
2017
Q2
$6.41M Buy
+104,800
New +$6.38M 2.54% 16

Other funds holding MRK

Pura Vida Investments's MRK Position: Q1 2022 in Review

Pura Vida Investments sold out of Merck (MRK) in Q1 2022, closing a stake of 24,246 shares — an estimated $1.86M sold.

Pura Vida Investments first reported a position in MRK in Q2 2017 and held it in 7 quarters. The position peaked at $9.9M in Q3 2017. 2,954 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Pura Vida Investments reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
  • Pura Vida Investments sold 24,246 Merck shares in Q1 2022, an estimated $1.86M.
  • Pura Vida Investments first reported a position in Merck in Q2 2017 and held it in 7 quarters.
  • Pura Vida Investments's Merck position peaked at $9.9M in Q3 2017.
  • 2,954 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.